Detailed Information
Cited 5 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kumar, R. | - |
| dc.contributor.author | Kim, S. H. | - |
| dc.contributor.author | Zhong, D. | - |
| dc.contributor.author | Lu, S. | - |
| dc.contributor.author | Cheng, Y. | - |
| dc.contributor.author | Chen, M. | - |
| dc.contributor.author | Cho, E. | - |
| dc.contributor.author | Clay, T. | - |
| dc.contributor.author | Kang, J. -H. | - |
| dc.contributor.author | Lee, G. -W. | - |
| dc.contributor.author | Sun, M. | - |
| dc.contributor.author | Shim, B. -Y. | - |
| dc.contributor.author | Spigel, D. R. | - |
| dc.contributor.author | Yang, T. -Y. | - |
| dc.contributor.author | Wang, Q. | - |
| dc.contributor.author | Chang, G. -C. | - |
| dc.contributor.author | Yu, G. | - |
| dc.contributor.author | Wang, R. | - |
| dc.contributor.author | Luo, X. | - |
| dc.contributor.author | Zheng, H. | - |
| dc.contributor.author | Gao, R. | - |
| dc.contributor.author | Kim, H. R. | - |
| dc.date.accessioned | 2023-01-03T02:14:01Z | - |
| dc.date.available | 2023-01-03T02:14:01Z | - |
| dc.date.issued | 2022-09 | - |
| dc.identifier.issn | 1556-0864 | - |
| dc.identifier.issn | 1556-1380 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/29769 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier Inc. | - |
| dc.title | AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.wosid | 000858678101093 | - |
| dc.identifier.bibliographicCitation | Journal of Thoracic Oncology, v.17, no.9, pp S375 - S376 | - |
| dc.citation.title | Journal of Thoracic Oncology | - |
| dc.citation.volume | 17 | - |
| dc.citation.number | 9 | - |
| dc.citation.startPage | S375 | - |
| dc.citation.endPage | S376 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Respiratory System | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Respiratory System | - |
| dc.subject.keywordAuthor | TIGIT antibody | - |
| dc.subject.keywordAuthor | PD-1 inhibitor | - |
| dc.subject.keywordAuthor | metastatic NSCLC | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.